프로그램

- 세미나 장소 : 아셈볼룸 [컨퍼런스룸(북), 2F] 201~202호

시 간 내 용 발표자
08:20~09:30 기자 간담회
09:00~09:40 등 록
09:40~10:00 개회사 및 축사
"How Artificial Intelligence can help Drug Discovery & Development"
(Collaboration& Innovation)
  Session 1 좌장
YoungWoo Pae,Ph.D.
(MediRita, CEO, KPBMA, Advisor for A.I.)
10:00∼10:30 "Disrupting drug discovery : How artificial intelligence is transforming drug research" IBM WatsonHealth
Pascal Sempé, Ph.D.
(Cognitive Solutions Specialist)
10:30∼11:00 "Pharma Databases Integration coupled with human curation for Drug Development/Repurposing" 3BIGS
Dawood Dudekula
(Head, Bioinformatics and Data Analysis)
11:00∼11:30 "Enabling AI & Advanced Analytics in Drug Discovery by building world’s largest research graph in Life Sciences" Innoplexus
Gunjan Bhardwaj, Ph.D.
(CEO)
11:30∼11:40 Q&A  
11:40∼13:10 점 심  
  Session 2 좌장
Woo Youn Kim, Ph.D.
(KAIST, Associate Professor)
13:10∼13:40 "Drug discovery space transforming hits and leads to clinical candidates" Standigm
Sang Ok Song, Ph.D.
(Chief Transformation Officer)
13:40∼14:10 "Using AI to bridge the gap between real biology and new drug candidates" Numerate
Guido Lanza
(CEO)
14:10∼14:40 "AI powered Drug Discovery initiative" DeNA
Keisuke Kobayashi
(Head, AI powered Drug Discovery Group)
14:40∼14:50 Q&A  
14:50∼15:20 휴 식  
  Session 3 좌장
Hojung Nam, Ph.D.
(GIST, Associate Professor)
15:20∼15:50 "Disrupting Drug Discovery Using Big Data and Artificial Intelligence" NuMedii
Michael Januszyk, M.D., Ph.D.
(Head, Translational Biomedical Informatics)
15:50∼16:20 "The role of genomic studies in drug development and how AI can accelerate the development" Syntekabio
Hyun-Jin Yang, Ph.D.
(Medical Science Liaison)
16:20∼16:50 "Discovering, Validating, & Launching First-In-Class Therapeutic Programs in 4 Months" twoXAR
Andrew Radin
(Co-Founder & Chief Marketing Officer)
16:50∼17:00 Q&A  
17:00 폐회사